(Re)Programming Director

Unwilling to accept the finality of terminal differentiation, Helen Blau has honed techniques that showcase the flexibility of cells to adopt different identities.

Written byKaren Hopkin
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Helen Blau was born in London and holds dual citizenship in the United States and the U.K. But she spent most of her childhood in Europe. “I loved that my family traveled so much,” says Blau, who attended summer schools in the Swiss Alps and lived with French and Austrian families. “The experience made me adventurous, encouraged me to take risks, and exposed me to different languages and cultures—all of which shaped my development.”

That same sense of unlimited possibilities ultimately guided her science. “I enjoy taking on new things,” says Blau. And she’s not afraid to question dogma.“When I was a student—an undergraduate and then graduate student—the dogma was that once mammalian cells were differentiated, that was it. Their fate was irreversibly set. That’s why it’s called terminal differentiation. But I didn’t like the idea that decisions were terminal, maybe because I grew up in different countries and I ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies